Evidence map›Paper›PMID 20941354›Full record

ArticlePLoS pathogens2010

Azole drugs are imported by facilitated diffusion in Candida albicans and other pathogenic fungi.

Bryce E Mansfield, Hanna N Oltean, Brian G Oliver, Samantha J Hoot, Sarah E Leyde, Lizbeth Hedstrom, Theodore C White

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 112 citations in OpenAlex.

  1. Article
  2. Comprehensive Insights into Sugar Transporters ofJournal of fungi (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Is theMicroorganisms · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Cell Wall Proteome Profiling of aMicroorganisms · 2021
    Article
  16. Article
  17. Transcriptome Signatures Predict Phenotypic Variations ofFrontiers in cellular and infection microbiology · 2021
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Bryce E MansfieldSeattle Biomedical Research Institute, Seattle, Washington, United States of America.
Hanna N Oltean
Brian G Oliver
Samantha J Hoot
Sarah E Leyde
Lizbeth Hedstrom
Theodore C White
Center for Infectious Disease Research · USBrandeis University · USUniversity of Washington · US

Funding

ORAL CANDIDIASIS IN LENTIVIRUS INFECTED MACAQUESR01DE011367 · NIDCR · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI WHITE, THEODORE C. · 1994 to 2007
$2.5M
AIDS Related Oral Candidiasis: Drugs, Sterols, and Fungal CellsR01DE017078 · NIDCR · SEATTLE BIOMEDICAL RESEARCH INSTITUTE · PI WHITE, THEODORE C. · 2006 to 2010
$2.1M
Azoles and Candida in AIDS - A Whole Cell ResponseR01DE014161 · NIDCR · SEATTLE BIOMEDICAL RESEARCH INSTITUTE · PI WHITE, THEODORE C. · 2001 to 2004
$1.4M
NIDCR NIH HHS DE11367NIDCR NIH HHS DE14161NIDCR NIH HHS DE17078NIDCR NIH HHS R01 DE011367NIDCR NIH HHS R01 DE014161NIDCR NIH HHS R01 DE017078
6 · The paper itself

Abstract

Despite the wealth of knowledge regarding the mechanisms of action and the mechanisms of resistance to azole antifungals, very little is known about how the azoles are imported into pathogenic fungal cells. Here the in-vitro accumulation and import of Fluconazole (FLC) was examined in the pathogenic fungus, Candida albicans. In energized cells, FLC accumulation correlates inversely with expression of ATP-dependent efflux pumps. In de-energized cells, all strains accumulate FLC, suggesting that FLC import is not ATP-dependent. The kinetics of import in de-energized cells displays saturation kinetics with a K(m) of 0.64 μM and V(max) of 0.0056 pmol/min/10⁸ cells, demonstrating that FLC import proceeds via facilitated diffusion through a transporter rather than passive diffusion. Other azoles inhibit FLC import on a mole/mole basis, suggesting that all azoles utilize the same facilitated diffusion mechanism. An analysis of related compounds indicates that competition for azole import depends on an aromatic ring and an imidazole or triazole ring together in one molecule. Import of FLC by facilitated diffusion is observed in other fungi, including Cryptococcus neoformans, Saccharomyces cerevisiae, and Candida krusei, indicating that the mechanism of transport is conserved among fungal species. FLC import was shown to vary among Candida albicans resistant clinical isolates, suggesting that altered facilitated diffusion may be a previously uncharacterized mechanism of resistance to azole drugs.

Indexed as

Antifungal AgentsCandida albicansCandidiasisCryptococcosisCryptococcus neoformansDiffusionDrug Resistance, FungalFluconazoleGene DeletionHumansOxygenSaccharomyces cerevisiaeAntifungal AgentsFluconazoleOxygen

Identifiers

PMID20941354
PMCPMC2947996
OpenAlexW1991753849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.